Indian Regulators Order Sun Pharma to Halt Assam Eye-Drop Production

Indian drug regulators directed Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products from its Assam facility after identifying significant quality-management deficiencies.